EP4419193A1 - Capacitance based dc charge-discharge cancer treatment device and method - Google Patents

Capacitance based dc charge-discharge cancer treatment device and method

Info

Publication number
EP4419193A1
EP4419193A1 EP22884188.8A EP22884188A EP4419193A1 EP 4419193 A1 EP4419193 A1 EP 4419193A1 EP 22884188 A EP22884188 A EP 22884188A EP 4419193 A1 EP4419193 A1 EP 4419193A1
Authority
EP
European Patent Office
Prior art keywords
cancer treatment
capacitive electrode
clothing
target region
treatment device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22884188.8A
Other languages
German (de)
French (fr)
Inventor
Purwo Taruno WARSITO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Revotera Medikal Teknolojiler AS
Original Assignee
Revotera Medikal Teknolojiler AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Revotera Medikal Teknolojiler AS filed Critical Revotera Medikal Teknolojiler AS
Priority claimed from PCT/TR2022/050854 external-priority patent/WO2023069043A1/en
Publication of EP4419193A1 publication Critical patent/EP4419193A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0472—Structure-related aspects
    • A61N1/0484—Garment electrodes worn by the patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36002—Cancer treatment, e.g. tumour

Definitions

  • the present invention relates to a cancer (including benign and malignant tumors) treatment device for treating of the cancer cells and preventing its recurrence and spread which exist in a target region of an individual.
  • Cancer cells have a higher electrical (dielectric) structure when compared with normal cells, therefore, when cancer cells are subjected to external electrical field, they face stronger electrical polarization when compared with normal cells.
  • micro-tubules play an important role in cell division process; first of all, in order to form two identical cell nuclei, micro-tubules attract replicated chromosomes, named as chromatid, towards the two division poles.
  • Micro-tubules are macro-protein compounds formed by polymerization process of smaller compounds named as tubulin dimers which construct spiral tubes having a pore at the center thereof and similar to the fiber threads at the cell nucleus microscopically.
  • Tubulin dimers which have high electrical polarity form the structure of micro-tubule polymer based on positive-negative electrostatic attraction named as van Der Waals bond.
  • Van Der Waals bond is a weak electrical bond which is very sensitive against the effect of external electrical field. The presence of an external electrical field may affect the orientation of tubulin dimer and may prevent the polymerization process for forming micro-tubular fibers, and consequently the chromatid separation process can be intervened during the cell division process, thus, since the cell division process does not function well, leading to selfdestruction.
  • the present invention relates to a cancer treatment device, for eliminating the abovementioned disadvantages and for bringing new advantages to the related technical field.
  • An object of the present invention is to treat the cancer cells while preventing its recurrence and spread of the cancer cells without needing electrode contact to the skin directly.
  • Another object of the present invention is to provide movement freedom to the patient during treatment.
  • Another object of the present invention is to provide a system and method where the electrical field intensity can be adjusted within a wider range when compared with the present methods and where the deviations in the field are reduced.
  • the present invention is a cancer treatment device for treating cancer cells and preventing of its recurrence and spread which exist at a target region.
  • said cancer treatment device comprises at least one first capacitive electrode for being positioned in the vicinity of said target region; a second capacitive electrode for being positioned against said first capacitive electrode such that the target region is positioned in between, and a signal generator for applying wave-formed DC signal to the first capacitive electrode and to the second capacitive electrode in order to provide formation of variable electrical field between said first capacitive electrode and said second capacitive electrode.
  • the capacitive electrodes are periodically charged at opposite polarization and this leads to electrical polarization on the outer face of the target region.
  • electrical polarization electrical waves are generated and these electrical waves penetrate in mediums of dielectric materials including air, fat or other body tissues which are not necessarily electrically conductive.
  • electrical field with desired intensity can be applied.
  • reproduction of the cancer cells which may exist in the body organs separated from the external surface of the body by body insulation layers where electrical current cannot pass, can also be prevented.
  • said first capacitive electrode and said second capacitive electrode are positioned such that a dielectrophoresis gap, which is equal to a predetermined distance, is provided between the outer face of the target region and the first capacitive electrode and the second capacitive electrode.
  • said distance is at least 1 mm.
  • said signal generator is configured to generate a signal which has square waveform.
  • the signal generator is configured to generate signal with 50% duty cycle.
  • the signal generator is configured to generate signal with frequencies which change between 100 kHz and 3 MHz.
  • said cancer treatment device comprises at least one grounding electrode associated with the grounding terminal and provided in the vicinity of the target region in a manner extending substantially parallel to the electrical field formed by the first capacitive electrode and the second capacitive electrode.
  • the present invention comprises a cancer treatment device as mentioned in any one of the above.
  • said cancer treatment clothing is upper body clothing.
  • said cancer treatment clothing is lower body clothing.
  • said cancer treatment clothing is a headwear.
  • said cancer treatment clothing is a vest.
  • said cancer treatment clothing comprises a front wall, a rear wall positioned against said front wall, and side walls positioned mutually and which bind said rear wall and said front wall to each other; the first capacitive electrode is provided on said front wall, the second capacitive electrode is provided on said rear wall.
  • one each grounding electrodes are provided on said side walls.
  • said cancer treatment clothing is a short.
  • the cancer treatment clothing in order to define a dielectrophoresis gap, is provided in abundant dimension such that there is distance of at least 1 mm as from the body of the user.
  • the present invention is moreover cancer treatment bed for preventing spread of cancer cells which exist at a target region. Accordingly, the novelty is that the present invention comprises a cancer treatment device as mentioned in any one of the above.
  • the cancer treatment bed comprises at least one base electrode where the first capacitive electrode is connected, a bed layer for lying of the patient and for providing a dielectrophoresis gap between said base electrode and the patient, a coverlet for covering the patient; a middle part provided longitudinally in the middle of said coverlet is connected to the second capacitive electrode.
  • the grounding electrode is provided at the edge parts on the two edges of the middle part.
  • the cancer treatment bed comprises a base part which is hollow and having open upper wall, a bed layer provided such that a dielectrophoresis gap remains between the base of said base part and said bed layer, a cover which will cover the bed layer and which will cover the patient who lies on the bed layer.
  • the present invention is moreover a method applied by a treatment bed, treatment clothing or treatment device as mentioned in any one of the above for treating of the cancer cells and preventing its recurrence and spread which exist in a target region of an individual.
  • the novelty is that the present invention is that a variable electrical field, which passes through the target region, is formed by a signal generator by means of at least one first capacitive electrode which is in the vicinity of said target region and having dielectrophoresis gap of at least 1 mm with respect to said target region, and by means of a second capacitive electrode which is against said first capacitive electrode and having dielectrophoresis gap of at least 1 mm with respect to said target region such that the target region is positioned between said first capacitive electrode and said second capacitive electrode.
  • the cancer cells mentioned in this specification describes benign tumors or malignant tumors.
  • the present invention is a cancer treatment device (100) for treating cancer cells (410) and for preventing spread of cancer cells (410) which exist at a target region (400).
  • the present invention comprises at least one first capacitive electrode (110) and a second capacitive electrode (120) for being positioned at said target region (400).
  • the first capacitive electrode (110) and the second capacitive electrode (120) are positioned such that the target region (400) is in between.
  • a signal generator (140) is provided.
  • the positive end of the signal generator (140) is connected to one of the capacitive electrodes and the negative end of the signal generator (140) is connected to the other one of the capacitive electrodes.
  • the signal generator (140) generates DC signals in waveform in a manner forming electrical field between the first capacitive electrode (110) and the second capacitive electrode (120), in other words, in a manner providing passage of electrical field through the target region (400). Thus, reproduction of the cancel cells (410) is prevented.
  • the signal generator (140) can be DC impact oscillator.
  • the mentioned target region (400) can be the body of a patient or a part of the body.
  • grounding electrodes are provided which are positioned in a parallel manner to the electrical field formed by the capacitive electrodes.
  • the grounding electrodes are placed in the vicinity of the target region (400).
  • the first capacitive electrodes (110) and the second capacitive electrodes (120) are placed in a parallel manner to each other and they take the target region (400) in between.
  • the grounding electrodes are placed mutually in a manner making an angle of 90 degrees with respect to the capacitive electrodes and in a parallel manner to each other and in a parallel manner to the electrical field generated by the capacitive electrodes.
  • the grounding electrodes and capacitive electrodes encircle the target region (400). Thanks to the grounding electrodes, the electrical field is intensified and passes by making reduced amount of electric fringing through the target region (400).
  • the grounding electrodes are not electrically connected to the capacitive electrodes.
  • the signal generator (140) generates square wave with 50% duty cycle.
  • the signal generator (140) generates signal at repetition frequencies formed between 50 to 150 kHz and generates signals which change between 100 kHz and 3 MHz.
  • the changes in the signal frequency can be controlled by a processor (not shown in the figures).
  • capacitive electrodes are positioned such that there is at least 1 mm air gap between said capacitive electrodes and the target region (400) outer surface.
  • This air gap is defined as a dielectrophoresis gap (360).
  • electrical field gradient occurs in the dielectrophoresis gap (360) and the dielectric constant difference between the capacitive electrodes and the target region (400) surface increases the electrical field force (dielectrophoresis) applied to the target region (400).
  • dielectric coefficient difference is increased.
  • the cancer treatment device (100) is provided in an embedded manner to cancer treatment clothing (200).
  • the cancer treatment clothing (200) can be upper body clothing (210).
  • the upper body clothing (210) comprises a front wall (201 ) provided in a manner corresponding to the front face of the upper body of the person who wears said clothing, a rear wall (202) provided in a manner corresponding to the rear face, and side walls (203) which join the front wall (201) and the rear wall (202).
  • the first capacitive electrode (110) and the second capacitive electrode (120) can be provided on said front wall (201 ) and on said rear wall (202); and the grounding electrodes (130) can be provided on the side walls (203).
  • dielectrophoresis gap (360) can be provided between the patient’s body and the electrodes.
  • the dielectrophoresis gap (360) can be provided by means of a fabric having suitable dielectric coefficient and having thickness of 1 mm.
  • the upper body clothing can be provided in vest form.
  • the cancer treatment clothing (200) can be a lower body clothing (220).
  • the lower body clothing (220) comprises a front wall (201) provided in a manner corresponding to the front face (groin region) of the lower body of the person who wears said clothing, a rear wall (202) provided in a manner corresponding to the rear face, and side walls (203) which join the front wall (201 ) and the rear wall (202).
  • the first capacitive electrode (110) and the second capacitive electrode (120) can be provided on said front wall (201) and on said rear wall (202); and the grounding electrodes (130) can be provided on the side walls (203).
  • Lower body clothing (220) is dimensioned in a manner positioned at least 1 mm away from the body of the patient.
  • the dielectrophoresis gap (360) can be provided between the body of the patient and the electrodes.
  • the dielectrophoresis gap (360) can be provided by means of a fabric having suitable dielectric coefficient and having thickness of 1 mm.
  • the lower body clothing (220) can be in short form.
  • the cancer treatment clothing (200) can be a headwear (230).
  • the headwear (230) can have a structure which completely encircles the head except the nose and the eye. Capacitive electrodes can be provided on the two mutual side regions at the sides of the head in a manner covering the ears, and grounding electrodes (130) can be provided at the parts which encircle the front, peak region, jaws and back regions of the head.
  • the headwear (230) is dimensioned in a manner positioned at least 1 mm away from the body of the patient.
  • the dielectrophoresis gap (360) can be provided between the body of the patient and the electrodes.
  • the dielectrophoresis gap (360) can be provided by means of a fabric having suitable dielectric coefficient and having thickness of 1 mm.
  • the lower body clothing (220) can be in short form.
  • the dielectrophoresis distances are 1 cm. With the distances of 1 cm, it has been detected that the treatment is the most efficient.
  • the cancer treatment device (100) can be provided in an integrated form to a treatment bed (300).
  • the treatment bed (300) comprises a bed layer (310) for lying of the patient, a base electrode (320) provided under said bed layer (310).
  • One of the first capacitive electrode (110) and the second capacitive electrode (120) has been integrated to the base electrode (320).
  • a coverlet (330) has been provided for covering the patient.
  • Said coverlet (330) is in rectangular form, and a central part (332), which extends in the direction of the height of the patient, comprises lateral parts (331) which remain at the edges of the middle part and which extend in the direction of the height of the patient.
  • the other one of the first capacitive electrode (110) and the second capacitive electrode (120) is provided at the central part (332). Grounding electrodes are provided at the lateral parts (331).
  • the headwear (230) and the treatment bed (300) can be used together.
  • An insulating pillow can be provided for resting of the head of the patient.
  • the cancer treatment device (100) has been integrated to a treatment bed (300) and the cancer treatment bed (300) is provided in a chamber form.
  • it comprises a conductive base part.
  • the base part is provided in a manner encircling a volume and such that an upper face thereof is open.
  • a bed layer (310) is provided for lying of the patient in the base part.
  • a dielectrophoresis gap (360) is provided between the base of the base part and the bed.
  • a cover (340) is provided for covering the patient.
  • the cover (340) can be electrically connected to the base part (350) such that the cover (340) and base part (350) together form a tubular chamber structure.
  • the cover (340) can be opened and closed on base part (350).
  • Grounding electrodes (130) are provided on the side walls (203) which connect the walls where the capacitive electrodes are provided.
  • the image of the cancer is obtained from PET, PET-MR-, PET-CT, MRI or CT DICOM, etc. images.
  • the characteristic of the electrical field, which will be applied, can be determined beforehand by utilizing this image. Said characteristics can be the electrical field force, and electrical field intensity distribution.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electrotherapy Devices (AREA)

Abstract

The present invention relates to a cancer treatment device (100) for preventing spreading of the cancer cells (410) which exist at a target region (400). Accordingly, said cancer treatment device (100) comprises at least one first capacitive electrode (110) for being positioned in the vicinity of said target region (400); a second capacitive electrode (120) for being positioned against said first capacitive electrode (110) such that the target region (400) is positioned in between, and a signal generator (140) for applying wave-formed DC signal to the first capacitive electrode (110) and to the second capacitive electrode (120) in order to provide formation of variable electrical field between said first capacitive electrode (110) and said second capacitive electrode (120).

Description

CAPACITANCE BASED DC CHARGE-DISCHARGE CANCER TREATMENT DEVICE AND METHOD
TECHNICAL FIELD
The present invention relates to a cancer (including benign and malignant tumors) treatment device for treating of the cancer cells and preventing its recurrence and spread which exist in a target region of an individual.
PRIOR ART
Cancer cells have a higher electrical (dielectric) structure when compared with normal cells, therefore, when cancer cells are subjected to external electrical field, they face stronger electrical polarization when compared with normal cells.
In cell division process, one characteristic of the cancer cells is that they have an uncontrollably high reproduction speed, and the electrical characteristics of the cells substantially increase as a result of cell bio-physical processes which are closely associated with the activity of the micro-tubules which exist in the cell nucleus. Micro-tubules play an important role in cell division process; first of all, in order to form two identical cell nuclei, micro-tubules attract replicated chromosomes, named as chromatid, towards the two division poles. Micro-tubules are macro-protein compounds formed by polymerization process of smaller compounds named as tubulin dimers which construct spiral tubes having a pore at the center thereof and similar to the fiber threads at the cell nucleus microscopically. Tubulin dimers which have high electrical polarity form the structure of micro-tubule polymer based on positive-negative electrostatic attraction named as van Der Waals bond. Van Der Waals bond is a weak electrical bond which is very sensitive against the effect of external electrical field. The presence of an external electrical field may affect the orientation of tubulin dimer and may prevent the polymerization process for forming micro-tubular fibers, and consequently the chromatid separation process can be intervened during the cell division process, thus, since the cell division process does not function well, leading to selfdestruction.
In the present art, it is known that AC electrical field, generated by means of conductive electrodes attached to the skin, prevents growth of the cancer cells at the region which remains between the electrodes. In the application with number US2007225766, this technology is described. In such systems, conductive gel is used for contact with the body and this leads to subjecting of the patients to electrical current. Since the amount of current which can be applied without giving damage to human body is limited, efficiency of the treatment decreases. When the area of electrodes is shorter than the distance between the two electrodes, fringing effect occurs and the intensity and field vectors of these fringes cannot be accurately controlled. Additionally, the desired intensity may not be given in case the tumor is at various positions such as metastatic cases to different body organs.
As a result, because of the abovementioned problems, an improvement is required in the related technical field.
BRIEF DESCRIPTION OF THE INVENTION
The present invention relates to a cancer treatment device, for eliminating the abovementioned disadvantages and for bringing new advantages to the related technical field.
An object of the present invention is to treat the cancer cells while preventing its recurrence and spread of the cancer cells without needing electrode contact to the skin directly.
Another object of the present invention is to provide movement freedom to the patient during treatment.
Another object of the present invention is to provide a system and method where the electrical field intensity can be adjusted within a wider range when compared with the present methods and where the deviations in the field are reduced.
In order to realize the abovementioned objects and the objects which are to be deducted from the detailed description below, the present invention is a cancer treatment device for treating cancer cells and preventing of its recurrence and spread which exist at a target region. Accordingly, said cancer treatment device comprises at least one first capacitive electrode for being positioned in the vicinity of said target region; a second capacitive electrode for being positioned against said first capacitive electrode such that the target region is positioned in between, and a signal generator for applying wave-formed DC signal to the first capacitive electrode and to the second capacitive electrode in order to provide formation of variable electrical field between said first capacitive electrode and said second capacitive electrode. Thus, the capacitive electrodes are periodically charged at opposite polarization and this leads to electrical polarization on the outer face of the target region. As a result of electrical polarization, electrical waves are generated and these electrical waves penetrate in mediums of dielectric materials including air, fat or other body tissues which are not necessarily electrically conductive. By means of this, electrical field with desired intensity can be applied. Additionally, reproduction of the cancer cells, which may exist in the body organs separated from the external surface of the body by body insulation layers where electrical current cannot pass, can also be prevented.
In a possible embodiment of the present invention, said first capacitive electrode and said second capacitive electrode are positioned such that a dielectrophoresis gap, which is equal to a predetermined distance, is provided between the outer face of the target region and the first capacitive electrode and the second capacitive electrode.
In another possible embodiment of the present invention, said distance is at least 1 mm. Thus, electrical field gradient occurs in the dielectrophoresis gap, and the dielectric constant difference between the capacitive electrodes and the target region surface increases the electrical field force (dielectrophoresis) applied to the target region.
In another possible embodiment of the present invention, said signal generator is configured to generate a signal which has square waveform.
In another possible embodiment of the present invention, the signal generator is configured to generate signal with 50% duty cycle.
In another possible embodiment of the present invention, the signal generator is configured to generate signal with frequencies which change between 100 kHz and 3 MHz.
In another possible embodiment of the present invention, said cancer treatment device comprises at least one grounding electrode associated with the grounding terminal and provided in the vicinity of the target region in a manner extending substantially parallel to the electrical field formed by the first capacitive electrode and the second capacitive electrode. Thus, electrical field is passed through the target region by minimizing fringing effect at the vicinity reducing the energy inefficiency while increasing treatment effectiveness.
In another possible embodiment of the present invention, two grounding electrodes are provided and are positioned mutually on two sides of the target region. The present invention is moreover cancer treatment clothing for preventing spread of cancer cells which exist at a target region. Accordingly, the novelty is that the present invention comprises a cancer treatment device as mentioned in any one of the above.
In another possible embodiment of the present invention, said cancer treatment clothing is upper body clothing.
In another possible embodiment of the present invention, said cancer treatment clothing is lower body clothing.
In another possible embodiment of the present invention, said cancer treatment clothing is a headwear.
In another possible embodiment of the present invention, said cancer treatment clothing is a vest.
In another possible embodiment of the present invention, said cancer treatment clothing comprises a front wall, a rear wall positioned against said front wall, and side walls positioned mutually and which bind said rear wall and said front wall to each other; the first capacitive electrode is provided on said front wall, the second capacitive electrode is provided on said rear wall.
In another possible embodiment of the present invention, one each grounding electrodes are provided on said side walls.
In another possible embodiment of the present invention, said cancer treatment clothing is a short.
In another possible embodiment of the present invention, in order to define a dielectrophoresis gap, the cancer treatment clothing is provided in abundant dimension such that there is distance of at least 1 mm as from the body of the user.
The present invention is moreover cancer treatment bed for preventing spread of cancer cells which exist at a target region. Accordingly, the novelty is that the present invention comprises a cancer treatment device as mentioned in any one of the above. In another possible embodiment of the present invention, the cancer treatment bed comprises at least one base electrode where the first capacitive electrode is connected, a bed layer for lying of the patient and for providing a dielectrophoresis gap between said base electrode and the patient, a coverlet for covering the patient; a middle part provided longitudinally in the middle of said coverlet is connected to the second capacitive electrode.
In another possible embodiment of the present invention, the grounding electrode is provided at the edge parts on the two edges of the middle part.
In another possible embodiment of the present invention, the cancer treatment bed comprises a base part which is hollow and having open upper wall, a bed layer provided such that a dielectrophoresis gap remains between the base of said base part and said bed layer, a cover which will cover the bed layer and which will cover the patient who lies on the bed layer.
The present invention is moreover a method applied by a treatment bed, treatment clothing or treatment device as mentioned in any one of the above for treating of the cancer cells and preventing its recurrence and spread which exist in a target region of an individual. Accordingly, the novelty is that the present invention is that a variable electrical field, which passes through the target region, is formed by a signal generator by means of at least one first capacitive electrode which is in the vicinity of said target region and having dielectrophoresis gap of at least 1 mm with respect to said target region, and by means of a second capacitive electrode which is against said first capacitive electrode and having dielectrophoresis gap of at least 1 mm with respect to said target region such that the target region is positioned between said first capacitive electrode and said second capacitive electrode.
BRIEF DESCRIPTION OF THE FIGURES
In Figure 1 , a representative view of an exemplary embodiment of the present invention is given.
In Figure 2a, 2b, 2c, 2d, representative views of the embodiment where the present invention is integrated to the clothing are given.
In Figure 3a, 3b, representative views of the embodiment where the present invention is integrated to the bed is given. In Figure 3c, a representative view of the connections of an embodiment of the present invention, where the embodiment integrated to the bed and the embodiment integrated to the clothing are used together, is given.
In Figure 4a, 4b, 4c and 4d, a representative view of an embodiment where the present invention is integrated to a bed, which is in chamber form, is given.
In Figure 4e, a representative view of the placement of the grounding electrodes, the first capacitive electrode and the second capacitive electrode in the embodiment where the present invention is integrated to a bed, which is in chamber form, is given.
DETAILED DESCRIPTION OF THE INVENTION
In this detailed description, the subject matter is explained with references to examples without forming any restrictive effect only in order to make the subject more understandable.
The cancer cells mentioned in this specification describes benign tumors or malignant tumors.
With reference to Figure 1 , the present invention is a cancer treatment device (100) for treating cancer cells (410) and for preventing spread of cancer cells (410) which exist at a target region (400). The present invention comprises at least one first capacitive electrode (110) and a second capacitive electrode (120) for being positioned at said target region (400). The first capacitive electrode (110) and the second capacitive electrode (120) are positioned such that the target region (400) is in between. A signal generator (140) is provided. The positive end of the signal generator (140) is connected to one of the capacitive electrodes and the negative end of the signal generator (140) is connected to the other one of the capacitive electrodes. The signal generator (140) generates DC signals in waveform in a manner forming electrical field between the first capacitive electrode (110) and the second capacitive electrode (120), in other words, in a manner providing passage of electrical field through the target region (400). Thus, reproduction of the cancel cells (410) is prevented. The signal generator (140) can be DC impact oscillator.
As the basic principle, capacitive electrodes are charged positively and negatively and thereby electrodes are charged and discharged. The charge and discharge process leads to polarization on the outer face of the target region. This electrical polarization generates the electrical waves which enter the target region (400) and which prevent reproduction of the cancer cells (410). In order for this effect to occur, the dielectric coefficient of the medium between the surface and the electrodes must be different from target region (400). In Figure 1 , the polarization which occurs on the outer face of the target region (400) and the electrical waves which occur as a result of this polarization and which pass through the cancer cell (410) are shown.
Here, the mentioned target region (400) can be the body of a patient or a part of the body.
In a possible embodiment of the present invention, grounding electrodes are provided which are positioned in a parallel manner to the electrical field formed by the capacitive electrodes. The grounding electrodes are placed in the vicinity of the target region (400). As can be seen in Figure 1 , the first capacitive electrodes (110) and the second capacitive electrodes (120) are placed in a parallel manner to each other and they take the target region (400) in between. The grounding electrodes are placed mutually in a manner making an angle of 90 degrees with respect to the capacitive electrodes and in a parallel manner to each other and in a parallel manner to the electrical field generated by the capacitive electrodes. The grounding electrodes and capacitive electrodes encircle the target region (400). Thanks to the grounding electrodes, the electrical field is intensified and passes by making reduced amount of electric fringing through the target region (400).
The grounding electrodes are not electrically connected to the capacitive electrodes.
In a possible embodiment of the present invention, the signal generator (140) generates square wave with 50% duty cycle. In more details, the signal generator (140) generates signal at repetition frequencies formed between 50 to 150 kHz and generates signals which change between 100 kHz and 3 MHz. The changes in the signal frequency can be controlled by a processor (not shown in the figures).
In a possible embodiment of the present invention, capacitive electrodes are positioned such that there is at least 1 mm air gap between said capacitive electrodes and the target region (400) outer surface. This air gap is defined as a dielectrophoresis gap (360). Thanks to this, electrical field gradient occurs in the dielectrophoresis gap (360) and the dielectric constant difference between the capacitive electrodes and the target region (400) surface increases the electrical field force (dielectrophoresis) applied to the target region (400). Moreover, dielectric coefficient difference is increased. With reference to Figure 2a, in a possible embodiment of the present invention, the cancer treatment device (100) is provided in an embedded manner to cancer treatment clothing (200).
In a possible embodiment of the present invention and with reference to Figure 2a-2b, the cancer treatment clothing (200) can be upper body clothing (210). The upper body clothing (210) comprises a front wall (201 ) provided in a manner corresponding to the front face of the upper body of the person who wears said clothing, a rear wall (202) provided in a manner corresponding to the rear face, and side walls (203) which join the front wall (201) and the rear wall (202). With reference to Figure 2a, the first capacitive electrode (110) and the second capacitive electrode (120) can be provided on said front wall (201 ) and on said rear wall (202); and the grounding electrodes (130) can be provided on the side walls (203). The upper body clothing (210) is dimensioned in a manner positioned at least 1 mm away from the body of the patient. Thus, dielectrophoresis gap (360) can be provided between the patient’s body and the electrodes. In a possible embodiment of the present invention, the dielectrophoresis gap (360) can be provided by means of a fabric having suitable dielectric coefficient and having thickness of 1 mm.
The upper body clothing can be provided in vest form.
In a possible embodiment of the present invention and with reference to Figure 2d, the cancer treatment clothing (200) can be a lower body clothing (220). The lower body clothing (220) comprises a front wall (201) provided in a manner corresponding to the front face (groin region) of the lower body of the person who wears said clothing, a rear wall (202) provided in a manner corresponding to the rear face, and side walls (203) which join the front wall (201 ) and the rear wall (202). With reference to Figure 2d, the first capacitive electrode (110) and the second capacitive electrode (120) can be provided on said front wall (201) and on said rear wall (202); and the grounding electrodes (130) can be provided on the side walls (203). Lower body clothing (220) is dimensioned in a manner positioned at least 1 mm away from the body of the patient. Thus, the dielectrophoresis gap (360) can be provided between the body of the patient and the electrodes. In a possible embodiment of the present invention, the dielectrophoresis gap (360) can be provided by means of a fabric having suitable dielectric coefficient and having thickness of 1 mm. The lower body clothing (220) can be in short form.
In a possible embodiment of the present invention and with reference to Figure 2c, the cancer treatment clothing (200) can be a headwear (230). The headwear (230) can have a structure which completely encircles the head except the nose and the eye. Capacitive electrodes can be provided on the two mutual side regions at the sides of the head in a manner covering the ears, and grounding electrodes (130) can be provided at the parts which encircle the front, peak region, jaws and back regions of the head. The headwear (230) is dimensioned in a manner positioned at least 1 mm away from the body of the patient. Thus, the dielectrophoresis gap (360) can be provided between the body of the patient and the electrodes. In a possible embodiment of the present invention, the dielectrophoresis gap (360) can be provided by means of a fabric having suitable dielectric coefficient and having thickness of 1 mm. The lower body clothing (220) can be in short form.
Thanks to the distances of at least 1 mm, the fringing effect at the ends of the body is reduced, the electrical field which enters the body is uniformed, the electrical field vortexes are reduced and the electrical field force is increased. In a possible embodiment of the present invention, the dielectrophoresis distances are 1 cm. With the distances of 1 cm, it has been detected that the treatment is the most efficient.
In a possible embodiment of the present invention, the cancer treatment device (100) can be provided in an integrated form to a treatment bed (300). With reference to Figure 3a-3b, the treatment bed (300) comprises a bed layer (310) for lying of the patient, a base electrode (320) provided under said bed layer (310). One of the first capacitive electrode (110) and the second capacitive electrode (120) has been integrated to the base electrode (320). A coverlet (330) has been provided for covering the patient. Said coverlet (330) is in rectangular form, and a central part (332), which extends in the direction of the height of the patient, comprises lateral parts (331) which remain at the edges of the middle part and which extend in the direction of the height of the patient. The other one of the first capacitive electrode (110) and the second capacitive electrode (120) is provided at the central part (332). Grounding electrodes are provided at the lateral parts (331).
In a possible embodiment of the present invention, the headwear (230) and the treatment bed (300) can be used together. An insulating pillow can be provided for resting of the head of the patient.
In a possible embodiment of the present invention as in Figure 4a-4b, the cancer treatment device (100) has been integrated to a treatment bed (300) and the cancer treatment bed (300) is provided in a chamber form. In more details, it comprises a conductive base part. The base part is provided in a manner encircling a volume and such that an upper face thereof is open. A bed layer (310) is provided for lying of the patient in the base part. A dielectrophoresis gap (360) is provided between the base of the base part and the bed. A cover (340) is provided for covering the patient. The cover (340) can be electrically connected to the base part (350) such that the cover (340) and base part (350) together form a tubular chamber structure. The cover (340) can be opened and closed on base part (350). Grounding electrodes (130) are provided on the side walls (203) which connect the walls where the capacitive electrodes are provided.
In a possible embodiment of the present invention, the image of the cancer is obtained from PET, PET-MR-, PET-CT, MRI or CT DICOM, etc. images. The characteristic of the electrical field, which will be applied, can be determined beforehand by utilizing this image. Said characteristics can be the electrical field force, and electrical field intensity distribution.
The protection scope of the present invention is set forth in the annexed claims and cannot be restricted to the illustrative disclosures given above, under the detailed description. It is because a person skilled in the relevant art can obviously produce similar embodiments under the light of the foregoing disclosures, without departing from the main principles of the present invention.
REFERENCE NUMBERS
100 Cancer treatment device
110 First capacitive electrode
120 Second capacitive electrode
130 Grounding electrode
140 Signal generator
200 Cancer treatment clothing
201 Front wall
202 Rear wall
203 Side wall
210 Upper body clothing
220 Lower body clothing
230 Headwear
300 Treatment bed
310 Bed layer
320 Base electrode
330 Coverlet
331 Lateral part
332 Central part
340 Cover
350 Base part
360 Dielectrophoresis gap
400 Target region
410 Cancer cell

Claims

1. A cancer treatment device (100) for preventing spread of the cancer cells (410) which exist at a target region (400), wherein said cancer treatment device (100) comprises at least one first capacitive electrode (110) for being positioned in the vicinity of said target region (400); a second capacitive electrode (120) for being positioned against said first capacitive electrode (110) such that the target region (400) is positioned in between, and a signal generator (140) for applying wave-formed DC signal to the first capacitive electrode (110) and to the second capacitive electrode (120) in order to provide formation of variable electrical field between said first capacitive electrode (110) and said second capacitive electrode (120).
2. The cancer treatment device (100) according to claim 1 , wherein said first capacitive electrode (110) and said second capacitive electrode (120) are positioned such that a dielectrophoresis gap (360), which is equal to a predetermined distance, is provided between the outer face of the target region (400) and the first capacitive electrode (110) and the second capacitive electrode (120).
3. The cancer treatment device (100) according to claim 2, wherein said distance is at least 1 mm.
4. The cancer treatment device (100) according to claim 1 , wherein said signal generator (140) is configured to generate a signal (140) which has square waveform.
5. The cancer treatment device (100) according to claim 4, wherein the signal generator (140) is configured to generate signal (140) with 50% duty cycle.
6. The cancer treatment device (100) according to claim 5, wherein the signal generator (140) is configured to generate signal (140) with frequencies which change between 100 kHz and 3 MHz.
7. The cancer treatment device (100) according to claim 1 , wherein said cancer treatment device (100) comprises at least one grounding electrode (130) associated with the grounding terminal and provided in the vicinity of the target region (400) in a manner extending substantially parallel to the electrical field formed by the first capacitive electrode (110) and the second capacitive electrode (120).
8. The cancer treatment device (100) according to claim 7, wherein two grounding electrodes (130) are provided and are positioned mutually on two sides of the target region (400).
9. A cancer treatment clothing (200) for treating and preventing the recurrence and spread of the cancer cells (410) which exist at a target region (400), wherein a cancer treatment device (100) is provided according to claims between claims 1-8.
10. The cancer treatment clothing (200) according to claim 9, wherein said cancer treatment clothing (200) is an upper body clothing (210).
11. The cancer treatment clothing (200) according to claim 9, wherein said cancer treatment clothing (200) is a lower body clothing (220).
12. The cancer treatment clothing (200) according to claim 9, wherein said cancer treatment clothing (200) is a headwear (230).
13. The cancer treatment clothing (200) according to claim 10, wherein said cancer treatment clothing (200) is a vest.
14. The cancer treatment clothing (200) according to claim 10 or 11 , wherein said cancer treatment clothing (200) comprises a front wall (201 ), a rear wall (202) positioned against said front wall (201 ), and side walls (203) positioned mutually and which bind said rear wall (202) and said front wall (201) to each other; the first capacitive electrode (110) is provided on said front wall (201), the second capacitive electrode (120) is provided on said rear wall (202).
15. The cancer treatment clothing (200) according to claim 13, wherein one each grounding electrodes (130) are provided on said side walls (203).
16. The cancer treatment clothing (200) according to claim 11 , wherein said cancer treatment clothing (200) is a short.
17. The cancer treatment clothing (200) according to claim 9, wherein in order to define a dielectrophoresis gap (360), the cancer treatment clothing (200) is provided in abundant dimension such that there is distance of at least 1 mm as from the body of the user. 14
18. A cancer treatment bed (300) for treating and preventing the recurrence and spread of the cancer cells (410) which exist at a target region (400), wherein a cancer treatment device (100) is provided according to claims between claims 1 -8.
19. The cancer treatment bed (300) according to claim 18, wherein the cancer treatment bed (300) comprises at least one base electrode (320) where the first capacitive electrode (110) is connected, a bed layer (310) for lying of the patient and for providing a dielectrophoresis gap (360) between said base electrode (320) and the patient, a coverlet (330) for covering the patient; a middle part provided longitudinally in the middle of said coverlet (330) is connected to the second capacitive electrode (120).
20. The cancer treatment bed (300) according to claim 19, wherein the grounding electrode (130) is provided at the edge parts on the two edges of the middle part.
21. The cancer treatment bed (300) according to claim 18, wherein the cancer treatment bed (300) comprises a base part (350) which is hollow and having open upper wall, a bed layer (310) provided such that a dielectrophoresis gap (360) remains between the base of said base part (350) and said bed layer (310), a cover (340) which will cover the bed layer (310) and which will cover the patient who will lye on the bed layer (310).
22. A method applied by a cancer treatment device (100) according to claims 1-8, a cancer treatment clothing (200) according to claims 9-18 or a treatment bed (300) according to claims 19-21 for treating and preventing the recurrence and spread of the cancer cells (410) which exist at a target region (400), wherein a variable electrical field, which passes through the target region (400), is formed by a signal generator (140) by means of at least one first capacitive electrode (110) which is in the vicinity of said target region (400) and having dielectrophoresis gap (360) of at least 1 mm with respect to said target region (400), and by means of a second capacitive electrode (120) which is against said first capacitive electrode (110) and having dielectrophoresis gap (360) of at least 1 mm with respect to said target region (400) such that the target region (400) is positioned between said first capacitive electrode (110) and said second capacitive electrode (120).
EP22884188.8A 2021-10-18 2022-08-15 Capacitance based dc charge-discharge cancer treatment device and method Pending EP4419193A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR202116189 2021-10-18
PCT/TR2022/050854 WO2023069043A1 (en) 2021-10-18 2022-08-15 Capacitance based dc charge-discharge cancer treatment device and method

Publications (1)

Publication Number Publication Date
EP4419193A1 true EP4419193A1 (en) 2024-08-28

Family

ID=92075753

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22884188.8A Pending EP4419193A1 (en) 2021-10-18 2022-08-15 Capacitance based dc charge-discharge cancer treatment device and method

Country Status (1)

Country Link
EP (1) EP4419193A1 (en)

Similar Documents

Publication Publication Date Title
US11654279B2 (en) Applying tumor treating fields (TTFields) via electrodes embedded into skull implants
JP4750784B2 (en) Treatment of tumors by electric fields of different frequencies
US10143843B2 (en) Systems and methods for stimulating cellular function in tissue
US7519420B2 (en) Apparatus for selectively destroying dividing cells
JP4350042B2 (en) Apparatus for treating tumors and the like, as well as a product comprising a device for treating tumors
EP1916013B1 (en) Hyperthermia device for the selective treatment and monitoring of surface tissue
JP5559460B2 (en) Method for treating tumors or the like using electric fields of different orientations
CN101500644A (en) Apparatus and method for stimulation of biological tissue
EP4419193A1 (en) Capacitance based dc charge-discharge cancer treatment device and method
WO2023069043A1 (en) Capacitance based dc charge-discharge cancer treatment device and method
CN117098577A (en) Amplitude modulation for tumor treatment fields
CN112473009B (en) Tumor therapeutic equipment
CN114377296B (en) Noninvasive deep brain electromagnetic coupling nerve regulation and control device
Agoramurthy et al. Tumor electric field distribution studies using various electrodes configurations
KR101953615B1 (en) Applicator using metal plate and short stub for brain stimulation
CN221932871U (en) Transducer array and tumor electric field treatment system
TWI805954B (en) Applying tumor treating fields (ttfields) via electrodes embedded into skull implants
JPS6021769A (en) Heating method of deep affected part in heating treatment
CN114225215A (en) Electrode system
CN110051933A (en) A kind of wearable device inhibiting pathological tissues fast-growth using electromagnetic wave
Gabran et al. Electromagnetic modeling and design optimization of intra-cortical micro-electrodes

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20240509

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR